Welcome to Paid Research Studies




  • Condition:   Endometriosis
    Interventions:   Drug: Elagolix;   Other: Placebo for Elagolix;   Drug: Estradiol/Norethindrone Acetate;   Other: Placebo for E2/NETA
    Sponsor:   AbbVie
    Recruiting - verified July 2017

  • Condition:   Contraception
    Intervention:   Drug: Levonorgestrel IUS (Mirena, BAY86-5028)
    Sponsor:   Bayer
    Recruiting - verified June 2017

  • Condition:   HIV Prevention
    Interventions:   Drug: Ring 104;   Drug: Ring 102
    Sponsors:   International Partnership for Microbicides, Inc.;   National Institutes of Health (NIH)
    Recruiting - verified June 2017

  • Condition:   Community Acquired Bacterial Pneumonia
    Interventions:   Drug: Delafloxacin;   Drug: Moxifloxacin;   Drug: Linezolid
    Sponsor:   Melinta Therapeutics, Inc.
    Recruiting - verified July 2017

  • Condition:   HIV Infections
    Interventions:   Drug: atazanavir/cobicistat;   Drug: darunavir/ritonavir;   Drug: darunavir/cobicistat;   Drug: etravirine;   Drug: elvitegravir/cobicistat;   Drug: dolutegravir;   Drug: tenofovir alafenamide fumarate (TAF);   Drug: TAF/cobicistat;   Drug: TAF/ritonavir;   Drug: efavirenz;   Drug: lopinavir/ritonavir;   Drug: nevirapine;   Drug: rifampicin;   Drug: ethambutol;   Drug: isoniazid;   Drug: pyrazinamide;   Drug: rifampicin;   Drug: kanamycin;   Drug: amikacin;   Drug: capreomycin;   Drug: moxifloxacin;   Drug: levofloxacin;   Drug: ofloxacin;   Drug: ethionamide/prothionamide;   Drug: terizidone/cycloserine;   Drug: para-aminosalicylic acid (PAS);   Drug: high dose isoniazid (INH);   Drug: bedaquiline;   Drug: clofazamine;   Drug: delamanid;   Drug: linezolid;   Drug: pretomanid;   Drug: atazanavir/ritonavir/tenofovir;   Drug: ethinyl estradiol oral contraceptive;   Drug: etonogestrel implant
    Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting - verified May 2017